Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting

Brandon A Van Noord, Andrew H Lin, Jeffery J CavendishDepartment of Cardiology, Naval Medical Center San Diego, San Diego, California, USAAbstract: Percutaneous transluminal angioplasty (PTA) and stenting is commonly used to treat subclavian artery stenosis (SAS). In this study, the outcomes of 43 c...

Full description

Bibliographic Details
Main Authors: Brandon A Van Noord, Andrew H Lin, Jeffery J Cavendish
Format: Article
Language:English
Published: Dove Medical Press 2007-11-01
Series:Vascular Health and Risk Management
Online Access:https://www.dovepress.com/rates-of-symptom-reoccurrence-after-endovascular-therapy-in-subclavian-peer-reviewed-article-VHRM
id doaj-dddcc976abb14db999918c40466e5fe5
record_format Article
spelling doaj-dddcc976abb14db999918c40466e5fe52020-11-24T22:55:55ZengDove Medical PressVascular Health and Risk Management1178-20482007-11-01Volume 37597621518Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass graftingBrandon A Van NoordAndrew H LinJeffery J CavendishBrandon A Van Noord, Andrew H Lin, Jeffery J CavendishDepartment of Cardiology, Naval Medical Center San Diego, San Diego, California, USAAbstract: Percutaneous transluminal angioplasty (PTA) and stenting is commonly used to treat subclavian artery stenosis (SAS). In this study, the outcomes of 43 consecutive cases, performed at one institution from October 1997 to October 2005, were analyzed. Mean stenosis was 84.41% pre-intervention and 6.83% post-intervention. Five of the procedures were angioplasty alone; 38 were angioplasty with stenting. Technical success was achieved in 42 out of 43 patients. The 30-day mortality rate was 0%. At one-month post intervention, all patients were symptom free. Ten patients redeveloped symptoms by one year. Demographic data, patient comorbidities, and indication to treat were analyzed. It was found that prior coronary intervention led to a statistically significant higher rate of symptom reoccurrence (p = 0.036). Additionally, a divergence in the rate of symptom reoccurrence based on indication to treat SAS was noted with the highest rate of symptom reoccurrence in the pre-coronary artery bypass grafting (CABG) group and the lowest rate of symptom reoccurrence in the subclavian steal syndrome (SSS) group. The coronary subclavian steal (CSS) group had an intermediate rate of symptom reoccurrence. During this time period, 1154 CABGs were performed. Flow-limiting stenosis was noted on angiography in 17 of these patients, giving pre-CABG prevalence of 1.46%.Keywords: subclavian artery stenosis, coronary steal syndrome, subclavian steal syndrome, coronary artery bypass graft, percutaneous intervention, restenosishttps://www.dovepress.com/rates-of-symptom-reoccurrence-after-endovascular-therapy-in-subclavian-peer-reviewed-article-VHRM
collection DOAJ
language English
format Article
sources DOAJ
author Brandon A Van Noord
Andrew H Lin
Jeffery J Cavendish
spellingShingle Brandon A Van Noord
Andrew H Lin
Jeffery J Cavendish
Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
Vascular Health and Risk Management
author_facet Brandon A Van Noord
Andrew H Lin
Jeffery J Cavendish
author_sort Brandon A Van Noord
title Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
title_short Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
title_full Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
title_fullStr Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
title_full_unstemmed Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
title_sort rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
publisher Dove Medical Press
series Vascular Health and Risk Management
issn 1178-2048
publishDate 2007-11-01
description Brandon A Van Noord, Andrew H Lin, Jeffery J CavendishDepartment of Cardiology, Naval Medical Center San Diego, San Diego, California, USAAbstract: Percutaneous transluminal angioplasty (PTA) and stenting is commonly used to treat subclavian artery stenosis (SAS). In this study, the outcomes of 43 consecutive cases, performed at one institution from October 1997 to October 2005, were analyzed. Mean stenosis was 84.41% pre-intervention and 6.83% post-intervention. Five of the procedures were angioplasty alone; 38 were angioplasty with stenting. Technical success was achieved in 42 out of 43 patients. The 30-day mortality rate was 0%. At one-month post intervention, all patients were symptom free. Ten patients redeveloped symptoms by one year. Demographic data, patient comorbidities, and indication to treat were analyzed. It was found that prior coronary intervention led to a statistically significant higher rate of symptom reoccurrence (p = 0.036). Additionally, a divergence in the rate of symptom reoccurrence based on indication to treat SAS was noted with the highest rate of symptom reoccurrence in the pre-coronary artery bypass grafting (CABG) group and the lowest rate of symptom reoccurrence in the subclavian steal syndrome (SSS) group. The coronary subclavian steal (CSS) group had an intermediate rate of symptom reoccurrence. During this time period, 1154 CABGs were performed. Flow-limiting stenosis was noted on angiography in 17 of these patients, giving pre-CABG prevalence of 1.46%.Keywords: subclavian artery stenosis, coronary steal syndrome, subclavian steal syndrome, coronary artery bypass graft, percutaneous intervention, restenosis
url https://www.dovepress.com/rates-of-symptom-reoccurrence-after-endovascular-therapy-in-subclavian-peer-reviewed-article-VHRM
work_keys_str_mv AT brandonavannoord ratesofsymptomreoccurrenceafterendovasculartherapyinsubclavianarterystenosisandprevalenceofsubclavianarterystenosispriortocoronaryarterybypassgrafting
AT andrewhlin ratesofsymptomreoccurrenceafterendovasculartherapyinsubclavianarterystenosisandprevalenceofsubclavianarterystenosispriortocoronaryarterybypassgrafting
AT jefferyjcavendish ratesofsymptomreoccurrenceafterendovasculartherapyinsubclavianarterystenosisandprevalenceofsubclavianarterystenosispriortocoronaryarterybypassgrafting
_version_ 1725655848064122880